Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Head and Neck CancerPrecancerous Condition
Interventions
BIOLOGICAL

cetuximab

given IV

Trial Locations (10)

10010

NYU Cancer Institute at New York University Medical Center, New York

15232

UPMC Cancer Centers, Pittsburgh

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

60637-1470

University of Chicago Cancer Research Center, Chicago

40536-0093

Lucille P. Markey Cancer Center at University of Kentucky, Lexington

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

48109-0942

University of Michigan Comprehensive Cancer Center, Ann Arbor

V5Z 4E6

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00524017 - Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract | Biotech Hunter | Biotech Hunter